Immunologische Bedeutung humaner Keratinozyten

  • J. Hunyadi
  • M. SimonJr.
  • A. Dobozy

Zusammenfassung

In den letzten Jahren sind bezüglich der immunologischen Eigenschaften humaner Keratinozyten viele neue Erkenntnisse ermittelt worden, die diese Zellen heute in neuem Licht als aktive Immunzellen erscheinen lassen. Im folgenden wird über Oberflächenmarkereigenschaften, Zytokin- und Lipid-Mediatoren-Produktion humaner Keratinozyten sowie ihre funktionelle Bedeutung aus immunologischer Sicht ein aktueller Überblick gegeben.

Summary

Experimental data of the last few years concerning various immunological properties of human keratinocytes strongly suggest an immunocyte nature of these cells. This review. summarizes from the immunological point of view different surface markers, cytokine and arachidonic acid derivative production of human keratinocytes, with special reference to their functional significance.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aubock, J, Niederwieser, D, Romani, N, Fritsch, P, Huber, C: Human interferon-y induces expression of HLA-DR on keratinocytes and melanocytes. Arch. derm. Res. 277, 270–275 (1985)PubMedCrossRefGoogle Scholar
  2. 2.
    Baadsgaard, O, Wulf, H C, Wantzin, G L, Cooper, KD: UVB and UVC, but not UVA, potently induce the appearance of T6--DR+ antigen-presenting cells in human epidermis. J. invest. Derm. 89, 113–118 (1987)PubMedCrossRefGoogle Scholar
  3. 3.
    Backer, K L, Williams, M L, Goldyne, M: Mitomycin C-treated 3T3 fibroblasts used as feeder layers for human keratinocyte culture retain the capacity to generate eicosanoids. J. invest. Derm. 89, 536–539 (1987)CrossRefGoogle Scholar
  4. 4.
    Barker, J, Allen, M H, MacDonald, D M: The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin. J. invest. Derm. 93, 439–442 (1989)PubMedCrossRefGoogle Scholar
  5. 5.
    Ban, R M, Brain, S D, Black, A K, Camp, R D, Greaves, M W, Mallet, A I, Wong, E: Lipoxigenase products of arachidonic acid in inflamed skin. J. invest. Derm. 80, 345 (1983)Google Scholar
  6. 6.
    Barrandon, Y, Green, H: Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor and epidermal growth factor. Cell 50, 1131–1137 (1987)PubMedCrossRefGoogle Scholar
  7. 7.
    Barrandon, Y, Green, H: Three clonal types of keratinocyte with different capacities for multiplication. Proc. nat. Acad. Sci. (USA) 84, 2302–2306 (1987)CrossRefGoogle Scholar
  8. 8.
    Basham, T Y, Nickoloff, B J, Merigan, T C, Morhenn, V B: Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J. invest. Derm. 83, 88–90 (1984)PubMedCrossRefGoogle Scholar
  9. 9.
    Basham, T Y, Nickoloff, B J, Merigan, T C, Morhenn, V B: Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes. J. Interferon Res. 5, 23–27 (1985)PubMedCrossRefGoogle Scholar
  10. 10.
    Bell, T V, Harley, C B, Stetsko, D, Sauder, D N: Expression of mRNA homologous to interleukin 1 in human epidermal cells. J. invest. Derm. 88, 375–379 (1987)PubMedCrossRefGoogle Scholar
  11. 11.
    Beutner, E H, Jordon, R E, Chorzelski, T P: The immunopathology of pemphigus and bullous pemphigoid. J. invest. Derm. 51, 63–80 (1968)PubMedGoogle Scholar
  12. 12.
    Bisgaard, H: Vascular effect of leukotriene D4 in human skin. J. invest. Derm. 88, 109–114 (1987)PubMedCrossRefGoogle Scholar
  13. 13.
    Black, A K, Greaves, M W, Hensby, C N, Plummer, N A, Warin, A P: The effects of indomethacin in arachidonic acid and prostaglandin E2 and F2 levels in human skin after UVB and UVC irradiation. Br. J. clin. Pharmacol. 6, 261–266 (1978)PubMedGoogle Scholar
  14. 14.
    Black, A K, Fincham, N, Greaves, M W, Hensby, C N: Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 in human skin following ultraviolet B irradiation. Br. J. clin. Pharmacol. 10, 453–457 (1980)PubMedGoogle Scholar
  15. 15.
    Boyce, S T, Ham, R G: Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J. invest. Derm. 81, Suppl, 33–40 (1983)CrossRefGoogle Scholar
  16. 16.
    Burg, G, Kaudewitz, P, Eckert, F: Immunhistochemische Diagnostik in der Dermatologie. Hautarzt 38, Suppl, 69–75 (1987)Google Scholar
  17. 17.
    Camp, R, Derm, FF, Russell-Jones, R, Brain, S, Woolard, P, Greaves, M: Production of intraepidermal microabscesses by topical application of leukotriene B4. J. invest. Derm. 82, 202–204 (1984)PubMedCrossRefGoogle Scholar
  18. 18.
    Csatö, M, Bozöki, B, Hunyadi, J, Dobozy, A: Candida albicans phagocytosis by separated human epidermal cells. Arch. derm. Res. 279, 136–139 (1986)PubMedCrossRefGoogle Scholar
  19. 19.
    Csatö, M, Kenderessy, S. A, Dobozy, A: Enhancement of Candida albicans killing activity of separated human epidermal cells by ultraviolet radiation. Br. J. Derm. 116, 469–475 (1987)CrossRefGoogle Scholar
  20. 20.
    Csatö, M, Rosenbach, J, Möller, A, Czarnetzki, B M: Generation of platelet aggregating activity from murine epidermal cells. J. invest. Derm. 89, 440 (1987)Google Scholar
  21. 21.
    Chen, YX, Evans, R L, Pollak, M S, Lanier, L L, Phillips, J H, Rousso, C, Warner, N L, Brodsky, FM: Characterization and expression of HLA-DQ antigens defined by anti-Leu 10. Hum. Immunol. 10, 221–228 (1984)PubMedCrossRefGoogle Scholar
  22. 22.
    Cooper, K D, Neises, G R, Katz, S I: Antigen-presenting OKM5 melanophages appear in human epidermis after ultraviolet radiation. J. invest. Derm. 86, 363–370 (1986)PubMedCrossRefGoogle Scholar
  23. 23.
    Dale, I, Fagerhol, M K, Frigard, M: Quantitation of a highly immunogenic leukocyte antigen (LI) by radioimmunoassay: methodological evaluation. J. Immunol. Methods 65, 245–255 (1983)PubMedCrossRefGoogle Scholar
  24. 24.
    Dale, I, Brandtzaeg, P, Fagerhol, M K, Scott, H: Distribution of a new myelomonocytic antigen (LI) in human peripheral blood leukocytes: immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am. J. clin. Path. 84, 24–34 (1985)PubMedGoogle Scholar
  25. 25.
    Danner, M, Luger, T A: Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity. J. invest. Derm. 88, 353–361 (1987)PubMedCrossRefGoogle Scholar
  26. 26.
    Dinarello, C A: Biology of interleukin 1. FASEB J. 2, 108–115 (1988)PubMedGoogle Scholar
  27. 27.
    Downing, D T, Stewart, M E, Wertz, P W, Colton, S W, Abraham, W, Strauss, J S: Skin lipids: an update. J. invest. Derm. 88, Suppl, 2–6 (1987)CrossRefGoogle Scholar
  28. 28.
    Dreno, B, Milpied, B, Stalder, J, Guillet, G, Litoux, P: Keratinocyte T6 antigen expression after PUVA therapy. Acta derm.-vener. (Stockh.) 67, 406–410 (1987)Google Scholar
  29. 29.
    Drijkoningen, M, De Wolf-Peeters, C, Van Deen Oord, J J: Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. Arch. Path, labor. Med. 110, 321–325 (1986)Google Scholar
  30. 30.
    Dustin, M L, Singer, K H, Tuck, D T, Springer, T A: Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule-1 (ICAM-1). J. exp. Med. 167, 1323–1340 (1988)PubMedCrossRefGoogle Scholar
  31. 31.
    Fagerhol, M K, Dale, I, Andersson, T: A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull. Eur. Physiopath. Resp. 16, Suppl, 273–281 (1980)Google Scholar
  32. 32.
    Fichtelius, KE, Groth, O, Liden, S: The skin, a first level lymphoid organ? Int. Arch. Allergy 37, 607–620 (1970)PubMedCrossRefGoogle Scholar
  33. 33.
    Gabrielsen, T, Dale, I, Brandtzaeg, P, Hoel, P S, Fagerhol, M K, Larsen, T E, Thune, P O: Epidermal and dermal distribution of a myelomonocytic antigen (LI) shared by epithelial cells in various inflammatory skin diseases. J. Am. Acad. Derm. 15, 173–179 (1986)PubMedCrossRefGoogle Scholar
  34. 34.
    Gonwa, T, Picker, L, Raff, H, Goyert, S, Silver, J, Stobo, J: Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS an la determinant distinct from HLA-DR. J. Immun. (Baltimore) 130, 706–711 (1983)Google Scholar
  35. 35.
    Gowans, J L: Immunobiology of the small lymphocyte. In: Immunobiology. Good, R A, Fisher, D W (eds.), Sinauer Associates Inc., Stamford, CT (1973), p. 18Google Scholar
  36. 36.
    Greaves, M W, Sondergaard, J, McDonald-Gibson, W: Recovery of prostaglandins in human cutaneous inflammation. Br. med. J. 2, 258–260 (1971)PubMedCrossRefGoogle Scholar
  37. 37.
    Hammar ström, S, Lingren, J A, Marcelo, D, Duell, E A, Ander sson, T F, Voorhees, J J: Arachidonic acid transformation in normal and psoriatic skin. J. invest. Derm. 73, 180–183 (1979)CrossRefGoogle Scholar
  38. 38.
    Hausman, P, Raff, H, Gilbert, R, Picker, L, Stobo, J: T cells and macrophages involved in the autologous mixed lymphocyte reaction are required for the response to conventional antigens. J. Immun. (Baltimore) 125, 1374–1379 (1980)Google Scholar
  39. 39.
    Hunyadi, J, Simon, M Jr: Expression of OKM5 antigen on human keratinocytes in vitro upon stimulation with y-interferon. Acta derm.-vener. (Stockh.) 66, 527–530 (1986)Google Scholar
  40. 40.
    Hunyadi, J, Simon, M Jr: Human epidermal cells express Leu-11b antigens. Br. J. Derm. 116, 283–284 (1987)CrossRefGoogle Scholar
  41. 41.
    Ihle, J N, Rebar, L, Keller, K, Lee, J C, Hapel, A J: Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immun. Rev. 63, 5–32 (1982)PubMedCrossRefGoogle Scholar
  42. 42.
    Ihle, JL, Keller, J, Oroszlän, S, Henderson, L E, Copeland, TD, Fitch, E, Prystowsky, M B, Goldwasser, E, Schräder, J W, Palaszynski, E, Dy, M, Lebel, B: Biologic properties of homogenous interleukin 3. J. Immun. (Baltimore) 131, 282–287 (1983)Google Scholar
  43. 43.
    Katz, S I: The skin as an immunologic organ. A tribute to Marion B. Sulzberger. J. Am. Acad. Derm. 13, 530–535 (1985)PubMedCrossRefGoogle Scholar
  44. 44.
    King, L E: What does epidermal growth factor do and how does it do it? J. invest. Derm. 84, 165–167 (1985)PubMedCrossRefGoogle Scholar
  45. 45.
    Kligman, A M: The biology of the stratum corneum. In: The Epidermis. Montagna, W, Lobitz, W C (eds.) New York: Academic Press 1964, pp 387–433Google Scholar
  46. 46.
    Krägballe, K, Voorhees, J J: Arachidonic acid and leukotrienes in dermatology. J. invest. Derm. 81, 293–296 (1983)PubMedGoogle Scholar
  47. 47.
    Krägballe, K, Voorhees, J J, Geotzl, E J: Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils. J. invest. Derm. 88, 555–558 (1987)PubMedCrossRefGoogle Scholar
  48. 48.
    Kupper, T S, Coleman, D L, McGuire, J, Goldminz, D, Horowitz, M C: Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2. Proc. nat. Acad. Sei. (USA) 83, 4451–4455 (1986)CrossRefGoogle Scholar
  49. 49.
    Kupper, T S, McGuire, J: Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes. J. invest. Derm. 87, 570–573 (1986)PubMedCrossRefGoogle Scholar
  50. 50.
    Kupper, T S, Edelson, R L: The role of cytokines in the pathophysiology of T cell mediated skin disease. J. Derm. 14, 517–523 (1987)Google Scholar
  51. 51.
    Kupper, T S, Horowitz, M, Lee, F, Robb, R, Flood, P M: Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL-4, BSF-1) as an autocrine growth factor for a cloned antigen specific helper T cell. J. Immun. (Baltimore) 138, 4280–4287 (1987)Google Scholar
  52. 52.
    Kupper, T S: Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization. Adv. Derm. 3, 293–308 (1988)Google Scholar
  53. 53.
    Kupper, T S, Lee, F, Coleman, D, Chodakewitz, J, Flood, P, Horowitz, M: Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF). J. invest. Derm. 91, 185–188 (1988)PubMedCrossRefGoogle Scholar
  54. 54.
    Lee, J C, Hapel, A J, Ihle, J N: Constitutive production of a unique lymphokine (IL-3) by the WEHI-3 cell line. J. Immun. (Baltimore) 128, 2393–2398 (1982)Google Scholar
  55. 55.
    Lever, R, Turbitt, M, Sanderson, A, Mckie, R: Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J. invest. Derm. 89, 4–7 (1987)PubMedCrossRefGoogle Scholar
  56. 56.
    Lewis, R E, Buchsbaum, M, Whitaker, D, Murphy, G F: Intercellular adhesion molecule expression in the evolving human cutaneous delayed hypersensitivity reaction. J. invest. Derm. 93, 672–677 (1989)PubMedCrossRefGoogle Scholar
  57. 57.
    Lisby, S, Baadsgaard, O, Cooper, KD, Thomsen, K, Wantzin, G R L: Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaques stage. J. invest. Derm. 90, 716–719 (1988)PubMedCrossRefGoogle Scholar
  58. 58.
    Livden, J K: Fc receptors on keratinocytes in psoriasis. Arch. derm. Res. 280, 12–17 (1988)PubMedCrossRefGoogle Scholar
  59. 59.
    Luger, TA, Stadler, B M, Katz, SI, Oppenheim, J J: Epidermal cell (keratinocyte) derived thymocyte- activating factor (ETAF). J. Immun. (Baltimore) 127, 1493–1498 (1981)Google Scholar
  60. 60.
    Luger, TA: Possible relevance to dermatology of epidermal cell thymocyte-activating factor (ETAF). Am. J. Dermatopath. 5, 97–102 (1983)PubMedCrossRefGoogle Scholar
  61. 61.
    Luger, T A, Uchida, A, Köck, A, Colot, M, Micksche, M: Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. J. Immun. (Baltimore) 134, 2477–2483 (1985)Google Scholar
  62. 62.
    MacGlashan, D, Lichtenstein, L M: Mast cell and basophil derived mediators of allergic disease. In: Allergy: An International Textbook. Lessof, M H, Lee, T H, Kemeny, D M (eds.). John Wiley and Sons Ltd 1987, pp 201–216Google Scholar
  63. 63.
    McGarry, R C, Helfand, S L, Quarles, R H, Roder, J C: Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature (Lond.) 306, 376–378 (1983)CrossRefGoogle Scholar
  64. 64.
    Michel, L, Mencia-Huerta, J, Benveniste, J, Dubertrét, L: Biologic properties of LTB4 and Paf-aceter in vivo in human skin. J. invest. Derm. 88, 675–681 (1987)PubMedCrossRefGoogle Scholar
  65. 65.
    Mosmann, T, Cherwinski, H, Bond, M W, Geidlan, M, Coffmann, R: Two types of cloned T helper cell: definition according to cytokine profile. J. Immun. (Baltimore) 136, 2348–2352 (1986)Google Scholar
  66. 66.
    Nanney, L B, Magid, M, Stoschek, C M, King, L E: Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J. invest. Derm. 83, 385–393 (1984)PubMedCrossRefGoogle Scholar
  67. 67.
    Needleman, P: Commentary. Experimental criteria for evaluating prostaglandin biosynthesis and intrinsic function. Biochem. Pharmacol. 27, 1515–1518 (1978)PubMedCrossRefGoogle Scholar
  68. 68.
    Nickoloff, B J, Basham, T Y, Merigan, T C, Morhenn, V B: Antiproliferative effects of recombinant alpha and gamma interferon on cultured human keratinocytes. Lab. Invest. 51, 697–701 (1984)PubMedGoogle Scholar
  69. 69.
    Nickoloff, B J, Basham, T Y, Merigan, T C, Morhenn, V B: Cultured keratinocytes secrete a substance which inhibits allogenic lymphocyte proliferation. J. invest. Derm. 84, 302 (1985)CrossRefGoogle Scholar
  70. 70.
    Nicolas, J F, Kaiserlain, D, Dardenne, M, Faure, M, Thivolet, J: Epidermal cell derived lymphocyte differentiating factor (ELDIF) inhibits in vitro lymphoproliferative responses and interleukin 2 production. J. invest. Derm. 88, 161–166 (1987)PubMedCrossRefGoogle Scholar
  71. 71.
    Niedecken, H, Biltz, H, Bauer, R, Kreysel, H W: Reactivity of human keratinocytes with the antimonocytic monoclonal antibody anti-Leu M2. Dermatológica (Basel) 176, 170–175 (1988)CrossRefGoogle Scholar
  72. 72.
    Niedecken, H, Wehrmann, W, Bauer, R, Kreysel, H W: Reaction of human keratinocytes with the monoclonal antibody anti-Leu 11: an immunohistologic study. J. Am. Acad. Derm. 18, 504–510 (1988)PubMedCrossRefGoogle Scholar
  73. 73.
    Nordquist, R E, Olson, R L, Everett, M A: The transport, uptake and storage of ferritin in human epidermis. Arch. Derm. (Chicago) 94, 482–490 (1966)Google Scholar
  74. 74.
    Padilla, J M, Hensby, C N, Shroot, B, Civier, A, Ortonne, J P: Elevated levels of arachidonic acid and prostaglandins D2, E2, F2 and 6-oxo-PGFla in tuberculin delayed hypersensitivity. J. invest. Derm. 800, 346 (1983)Google Scholar
  75. 75.
    Pentland, A P, Needleman, P: Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. clin. Invest. 77, 246–251 (1986)PubMedCrossRefGoogle Scholar
  76. 76.
    Perussia, B, Trinchieri, G, Jackson, A, Warner, NL, Faust, J, Rumpold, H, Kraft, D, Lanier, L L: The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J. Immun. (Baltimore) 133, 180–189 (1984)Google Scholar
  77. 77.
    Petter, B, Medenica, M: Ultramicroscopic phagocytosis of synthetic melanin by epidermal cells in vivo. J. invest. Derm. 51, 300–303 (1968)Google Scholar
  78. 78.
    Pincelli, C, Girolomoni, G, Benassi, L: Expression of T6 antigen on the epidermal keratinocytes in various dermatoses. Br. J. Derm. 115, 511–518 (1986)CrossRefGoogle Scholar
  79. 79.
    Potten, C S: Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int. Rev. Cytol. 69, 271–318 (1981)PubMedCrossRefGoogle Scholar
  80. 80.
    Raff H, Picker, L, Stobo, J: Macrophage heterogenity in man. J. exp. Med. 152, 581–593 (1980)PubMedCrossRefGoogle Scholar
  81. 81.
    Räcz, I, Daröczy, J: Die Phagozytosefahigkeit der Epithelzellen. Hautarzt 28, Suppl. II, 244–245 (1977)Google Scholar
  82. 82.
    Rheinwald, J, Green, H: Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature (Lond.) 265, 421–424 (1977)CrossRefGoogle Scholar
  83. 83.
    Robertson, B, Gahring, L, Newton, R, Daynes, R: In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function. J. invest. Derm. 88, 380–387 (1987)PubMedCrossRefGoogle Scholar
  84. 84.
    Rola-Pleszczynski, M, Borgeat, P, Sirois, P: Leukotriene B4 induces human suppressor lymphocytes. Biochem. Biophys. Res. Commun. 108, 1531–1537 (1982)PubMedCrossRefGoogle Scholar
  85. 85.
    Rothlein, R, Dustin, M L, Marlin, S D, Springer, T A: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immun. (Baltimore) 137, 1270–1274 (1986)Google Scholar
  86. 86.
    Samuelsson, B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568–575 (1983)PubMedCrossRefGoogle Scholar
  87. 87.
    Sauder, D N, Katz, S I: Immune modulation by epidermal cell products: Possible role of ETAF in inflammatory and neoplastic skin diseases. J. Am. Acad. Derm. 7, 651–654 (1982)PubMedCrossRefGoogle Scholar
  88. 88.
    Sauder, D N, Stanulis-Praeger, B M, Gilchrest, B A: Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging. Arch, derm. Res. 280, 71–76 (1988)CrossRefGoogle Scholar
  89. 89.
    Schnipper, L E, Levin, M, Crumpacker, C S, Gilchrest, B A: Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus. J. invest. Derm. 82, 94–96 (1984)PubMedCrossRefGoogle Scholar
  90. 90.
    Schreiner, E, Wolff, K: Systemic lupus erythematosus: electron microscopic localization of in vivo bound globulins at the dermal-epidermal junction. J. invest. Derm. 55, 325–328 (1970)PubMedCrossRefGoogle Scholar
  91. 91.
    Shen, H H, Talle, M A, Goldstein, G, Chess, L: Functional subsets of monocytes defined by monoclonal antibodies: a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture. J. Immun. (Baltimore) 130, 698–705 (1983)Google Scholar
  92. 92.
    Shipley, G D, Pittelkow, M R, Wille, J J, Scott, R E, Moses, H L: Reversible inhibition of normal human prokeratinocyte proliferation by type ß transforming growth factor - growth inhibitor in serum-free medium. Cancer Res. 46, 2068–2071 (1986)PubMedGoogle Scholar
  93. 93.
    Simon, M Jr, Hunyadi, J: Expression of OKM5 antigen on human keratinocytes in positive intracutaneous tests for delayed-type hypersensitivity. Dermatologica (Basel) 175, 121–125 (1987)CrossRefGoogle Scholar
  94. 94.
    Simon, M Jr: Lesional keratinocytes express OKM5, Leu-8 and Leu-11b antigens in lichen planus. Dermatologica (Basel) 177, 152–158 (1988)CrossRefGoogle Scholar
  95. 95.
    Simon, M Jr, Hunyadi, J: Leu-11b (CD16) antigen expression on human keratinocytes. Arch. derm. Res. 280, 176–178 (1988)PubMedCrossRefGoogle Scholar
  96. 96.
    Smolle, J: HLA-DR-antigen bearing keratinocytes in various dermatological disorders. Acta, derm.- vener. (Stockh.) 65, 9–13 (1985)Google Scholar
  97. 97.
    Sondergaard, J, Greaves, M W, Joergensen, HP: Recovery of prostaglandins in human primary irritant dermatitis. Arch. Derm. (Chicago) 110, 556–558 (1974)Google Scholar
  98. 98.
    Stadler, B M, Week, A L AAA: Role of lymphokines in immediate type allergy. Springer Semin. Immunopath. 7, 415–424 (1984)Google Scholar
  99. 99.
    Tadokoro, K, Stadler, B M, Week, A L de: Factor dependent in vitro growth of human normal bone marrow derived basophil-like cells. J. exp. Med. 158, 857–871 (1983)PubMedCrossRefGoogle Scholar
  100. 100.
    Talle, M, Rao, P, Westberg, E, Allegar, N, Makowski, M, Mittler, R, Goldstein, G: Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell. Immun. 78, 83–99 (1983)CrossRefGoogle Scholar
  101. 101.
    Taylor, A, Hogan, BLM, Watt, FM: Biosynthesis of EGF receptor, transferrin receptor and colligin by cultured human keratinocytes and the effects of retinoic acid. Exp. Cell Res. 159, 47–54 (1985)PubMedCrossRefGoogle Scholar
  102. 102.
    Tjernlund, U M: Epidermal expression of HLA-DR antigens in mycosis fungoides. Arch. derm. Res. 261, 81–86 (1978)PubMedCrossRefGoogle Scholar
  103. 103.
    Tjernlund, U, Scheynius, A: Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes. Scand J. Immun. 26, 1–6 (1987)CrossRefGoogle Scholar
  104. 104.
    Torseth, J, Nikoloff B J, Basham, T Y, Merigan, T C: Keratinocytes produce beta interferon in human cutaneous herpes simplex infection. J. infect. Dis. 155, 641–648 (1987)PubMedCrossRefGoogle Scholar
  105. 105.
    Volc-Platzer, B, Leibi, H, Luger, T, Zahn, G, Stingl, G: Human epidermal cells synthetize HLA-DR alloantigens in vitro upon stimulation with y-interferon. J. invest. Derm. 85, 16–19 (1985)PubMedCrossRefGoogle Scholar
  106. 106.
    Volc-Platzer, B, Groh, V, Wolff, K: Differential expression of class II alloantigens by keratinocytes in disease. J. invest. Derm. 89, 64–68 (1987)PubMedCrossRefGoogle Scholar
  107. 107.
    Watt, F M: The epidermal keratinocyte. Bio Essays 8, 163–167 (1988)Google Scholar
  108. 108.
    Webb, D R, Nowowiejski, I, Healey, C, Rogers, T J: Immunosuppressive properties of leukotriene D4 and E4 in vitro. Biochem. Biophys. Res. Commun. 104, 1617–1622 (1982)PubMedCrossRefGoogle Scholar
  109. 109.
    Wolff, K, Schreiner, E: Aufnahme, intracellulärer Transport und Abbau exogenen Proteins in Keratinocyten. Eine elektronenmikroskopisch-cytochemische Studie mit Peroxidase als Markierungssubstanz. Arch. klin. exp. Derm. 235, 203–220 (1969)PubMedCrossRefGoogle Scholar
  110. 110.
    Wolff, K, Hönigsmann, H: Permeability of the epidermis and the phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as a marker. J. Ultrastruct. Res. 36, 176–190 (1971)PubMedCrossRefGoogle Scholar
  111. 111.
    Zachary, C B, Rauch, H J, MacDonald, D M: Shared antigenic determinants between cutaneous structures and the natural killer cell monoclonal antibodies Leu 7 and Leu 11. Clin. exp. Derm. 12, 256–259 (1987)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • J. Hunyadi
    • 1
  • M. SimonJr.
    • 1
    • 2
  • A. Dobozy
    • 1
  1. 1.Dermatologische Klinik der Szent-Györgyi Albert Medizinischen UniversitätSzegedDeutschland
  2. 2.Dermatologische Univ.-Klinik der Universität Erlangen-NürnbergErlangenDeutschland

Personalised recommendations